mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.072 |
0.2 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.2 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |